- Patent Title: Scalable synthesis of reduced toxicity derivative of amphotericin B
-
Application No.: US15519471Application Date: 2015-10-16
-
Publication No.: US10087206B2Publication Date: 2018-10-02
- Inventor: Martin D. Burke , Brice E. Uno , Souvik Rakshit
- Applicant: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
- Applicant Address: US IL Urbana
- Assignee: The Board of Trustees of the University of Illinois
- Current Assignee: The Board of Trustees of the University of Illinois
- Current Assignee Address: US IL Urbana
- Agency: Foley Hoag LLP
- Agent Dana M. Gordon
- International Application: PCT/US2015/055899 WO 20151016
- International Announcement: WO2016/061437 WO 20160421
- Main IPC: C07H17/08
- IPC: C07H17/08 ; C07H1/00

Abstract:
Disclosed is a simplified, readily scalable series of individual methods that collectively constitute a method for the synthesis of C2′epiAmB, an efficacious and reduced-toxicity derivative of amphotericin B (AmB), beginning from AmB. Also provided are various compounds corresponding to intermediates in accordance with the series of methods.
Public/Granted literature
- US20170233427A1 SCALABLE SYNTHESIS OF REDUCED TOXICITY DERIVATIVE OF AMPHOTERICIN B Public/Granted day:2017-08-17
Information query